Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-18

Clinical Trial Update: Sapropterin in Individuals With Phenylketonuria

View source ↗

Summary

This clinical trial update reports that a study evaluating sapropterin for phenylketonuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sapropterin dihydrochloride (Sapropterin dihydrochloride)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Phenylketonuria | Status: COMPLETED